# Zepp Health Corp: Form 20-F for the period ended Dec 31, 2018

- Company: [Zepp Health Corp](/companies/zepp.md) (CIK 1720446)
- Form: 20-F
- Filed: 2019-04-12
- Accepted by EDGAR: Apr 12, 2019, 08:06 ET
- Period: 2018-12-31
- Accession: 0001564590-19-011452
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1720446/000156459019011452/hmi-20f_20181231.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1720446/000156459019011452/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2018-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 12 months, 2018-01-01 to 2018-12-31 | $530.2m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 12 months, 2018-01-01 to 2018-12-31 | $393.6m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 12 months, 2018-01-01 to 2018-12-31 | $136.6m | us-gaap:GrossProfit |
| Research and development | 12 months, 2018-01-01 to 2018-12-31 | $38.3m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 12 months, 2018-01-01 to 2018-12-31 | $53.2m | us-gaap:OperatingIncomeLoss |
| Income tax | 12 months, 2018-01-01 to 2018-12-31 | $7.6m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months, 2018-01-01 to 2018-12-31 | $49.5m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months, 2018-01-01 to 2018-12-31 | $0.07 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months, 2018-01-01 to 2018-12-31 | $0.08 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months, 2018-01-01 to 2018-12-31 | 225,034,650 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months, 2018-01-01 to 2018-12-31 | $102.9m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months, 2018-01-01 to 2018-12-31 | $2.5m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 12 months, 2018-01-01 to 2018-12-31 | $1.2m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2018-12-31 | $209.7m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2018-12-31 | $415.6m | us-gaap:AssetsCurrent |
| Total assets | at 2018-12-31 | $473.9m | us-gaap:Assets |
| Current liabilities | at 2018-12-31 | $201.8m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2018-12-31 | $210.7m | us-gaap:Liabilities |
| Shareholders' equity | at 2018-12-31 | $263.4m | us-gaap:StockholdersEquity |

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1720446/000156459019011452/hmi-20f_20181231.htm

Filed Apr 12, 2019.
Source: SEC EDGAR, the filing index for accession 0001564590-19-011452. Last ingested by Listed: Nov 5, 2026, 14:06 ET. No prices; not investment advice.